Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

experspadmin

Interleukin-6 Inhibition in Patients With Rheumatoid Arthritis: Long-term Safety and Tolerability

Interleukin-6 Inhibition in Patients With Rheumatoid Arthritis: Long-term Safety and Tolerability

clinical topic updates
By Vibeke Strand, MD, MACR, FACP

Latest DMARD Prescribing Trends for Rheumatoid Arthritis in the United States

Latest DMARD Prescribing Trends for Rheumatoid Arthritis in the United States

clinical topic updates
By Leonard H. Calabrese, DO

Improving Bone Mineral Density in Patients With Rheumatoid Arthritis

Improving Bone Mineral Density in Patients With Rheumatoid Arthritis

patient care perspectives
By Vibeke Strand, MD, MACR, FACP

COVID-19: Considerations for Patients With Rheumatoid Arthritis

COVID-19: Considerations for Patients With Rheumatoid Arthritis

expert roundtables
By Jonathan Kay, MD; Leonard H. Calabrese, DO; Vibeke Strand, MD, MACR, FACP

Complications in Sickle Cell Disease: Beyond the Most Common Offenders

Complications in Sickle Cell Disease: Beyond the Most Common Offenders

expert roundtables
By Julie Kanter, MD; Michael Rutledge DeBaun, MD, MPH; Stella T. Chou, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?